I'll have to say, I don't know whether or not Mr. Bordynuik
I'll have to say, I don't know whether or not Mr. Bordynuik still owns shares in PTOI. He was quoted as saying he sold his shares but that information is being tortured.
Who exactly was able to read past every word in the article, focus on the phrase of Mr. Bordynuik saying he sold his shares, declare that false and then convert the whole article into a theme that Mr. Bordynuik still owns millions of shares?? What the...??!! Is that diversion an attempt to keep investors from talking about Mr. Bordynuik's latest venture and his saying that it's a much better investment than PTOI?
Personally I think every time someone references the article and announces their belief that Mr. Bordynuik owns millions of shares, the answer should be the simple rhetorical question, "Then why did he say that chemical recycling is a much better investment than PTOI??" Further argument is futile.
All of this minutia is pointless. There's a reason why neither Mr. Bordynuik nor Mr. Heddle ever released the results of the processor runs and that reason is not because those results are so amazing that it would compel investors to gobble up all of PTOI's shares at astronomically high prices. The reason is that the $10/bbl diesel and crude oil claims were fake...and Mr. Heddle doesn't want to open himself up to fraud charges by re-iterating those claims and he doesn't want to lose investors by showing the real results.
Plastic2Oil, Inc. (PTOI) Stock Research Links
Yes, I understand your penny stock also is the real deal, created with the inventiveness of Edison and destined to be the next Microsoft. Yes, I understand that the delays are also only because your company is making their product and/or technology even more revolutionary.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...
Continue Reading
Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....
Continue Reading
CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...
Continue Reading
A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...
Continue Reading
Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...
Continue Reading
University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...
Continue Reading
PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...
Continue Reading
Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...
Continue Reading
Top 5 Most Recently Viewed Articles
Exciting Leadership Move at Ten Four Truck Insurance Ten Four Truck Insurance, recognized as a premier provider of insurance solutions tailored specifically for the trucking industry, has recently elevated Chris Johnstone to the position of Director of Partnerships. This strategic appointment is set to enhance the company's collaborative efforts and broaden its partner...
Continue Reading
Revolutionizing the Concrete Construction Process In the bustling world of construction, efficiency is key. An inventive mind has recently introduced a specialized screed hook that promises to streamline the concrete pouring process significantly. This innovation is designed with a focus on ease of use, making it a practical addition for contractors and workers alike....
Continue Reading
SCR Expands Offerings Through Global Partnerships In recent developments, SCR has made significant strides in enhancing its Offshore Company Formation services by forging international partnerships. These collaborations provide businesses and individuals with increased flexibility in establishing structures that can facilitate asset protection, succession planning, and...
Continue Reading
Response Pharmaceuticals Makes Significant Progress in Clinical Trial Response Pharmaceuticals, Inc., a company specializing in innovative weight management solutions, has announced a pivotal moment in its clinical trajectory. The firm has completed early enrollment in a Phase 2 clinical trial assessing the efficacy of its investigational drug candidate, RDX-002. This...
Continue Reading
Fifth Third Bancorp Reports Lower Profits Amid Rising Provisions Fifth Third Bancorp (NASDAQ: FITB), a prominent financial institution, has reported a decrease in its profits for the third quarter, primarily influenced by heightened provisions for loan losses. The bank's recent financial disclosures have caught the attention of investors, culminating in a nearly 3% drop...
Continue Reading